NCT01840956 - Safety and Efficacy of a Vascular Prosthesis for Hemodialysis Access in Patients With End-Stage Renal Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 23, 2013

Primary Completion Date

April 28, 2016

Study Completion Date

April 28, 2016

Conditions

End-stage Renal DiseaseKidney Failure, Chronic

Interventions

BIOLOGICAL

HAVG

HAVG is implanted into patients' arm.

Trial Locations (3)

Sentara Norfolk General Hospital Vascular & Transplant Specialists, Norfolk

Duke University Medical Center Department of Vascular Surgery, Durham

The Methodist Hospital, Houston